Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,042 | 93 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Antares Pharma, Inc. | $1,046 | 60 | $0 (2023) |
| Medtronic Vascular, Inc. | $391.97 | 5 | $0 (2020) |
| Supernus Pharmaceuticals, Inc. | $151.43 | 6 | $0 (2023) |
| Lundbeck LLC | $76.85 | 3 | $0 (2021) |
| Corium, LLC | $59.13 | 3 | $0 (2023) |
| Medtronic, Inc. | $56.52 | 1 | $0 (2023) |
| Novo Nordisk Inc | $50.81 | 3 | $0 (2023) |
| Biohaven Pharmaceuticals, Inc. | $41.62 | 2 | $0 (2021) |
| BOSTON SCIENTIFIC CORPORATION | $33.69 | 3 | $0 (2018) |
| Ethicon US, LLC | $25.23 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $379.91 | 16 | Antares Pharma, Inc. ($129.55) |
| 2022 | $536.70 | 34 | Antares Pharma, Inc. ($503.76) |
| 2021 | $535.08 | 27 | Antares Pharma, Inc. ($347.77) |
| 2020 | $116.53 | 6 | Antares Pharma, Inc. ($65.27) |
| 2018 | $183.62 | 3 | Medtronic Vascular, Inc. ($172.50) |
| 2017 | $290.08 | 7 | Medtronic Vascular, Inc. ($206.83) |
All Payment Transactions
93 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2023 | Supernus Pharmaceuticals, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/25/2023 | Supernus Pharmaceuticals, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/30/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Neurology | ||||||
| 08/24/2023 | Supernus Pharmaceuticals, Inc. | TLANDO (Drug), XYOSTED | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/09/2023 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $56.52 | General |
| Category: EndoVenous Therapies | ||||||
| 08/08/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 06/28/2023 | Supernus Pharmaceuticals, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 06/28/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $9.23 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 06/01/2023 | Antares Pharma, Inc. | NOCDURNA (Drug), TLANDO, XYOSTED | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 05/31/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: Obesity | ||||||
| 05/10/2023 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 04/07/2023 | Antares Pharma, Inc. | NOCDURNA (Drug), TLANDO, XYOSTED | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 04/05/2023 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 03/15/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 02/08/2023 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 01/19/2023 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 12/20/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 12/08/2022 | Antares Pharma, Inc. | XYOSTED (Drug), TLANDO, NOCDURNA | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/05/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), TLANDO, XYOSTED | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 11/21/2022 | Antares Pharma, Inc. | XYOSTED (Drug), TLANDO, NOCDURNA | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/21/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), TLANDO, XYOSTED | Food and Beverage | In-kind items and services | $6.80 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 11/21/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), TLANDO, XYOSTED | Food and Beverage | In-kind items and services | $6.60 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 11/15/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), TLANDO, XYOSTED | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 10/20/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 10/12/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 135 | 157 | $201,394 | $41,435 |
| 2022 | 4 | 72 | 84 | $35,171 | $8,516 |
| 2021 | 3 | 54 | 68 | $100,179 | $22,733 |
| 2020 | 4 | 64 | 84 | $139,074 | $35,572 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 36475 | Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | Office | 2023 | 24 | 32 | $145,050 | $29,524 | 20.4% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 28 | 29 | $14,150 | $3,968 | 28.0% |
| 36471 | Injection of chemical agent into multiple incompetent veins of leg | Office | 2023 | 25 | 35 | $21,344 | $3,245 | 15.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 34 | 34 | $12,750 | $2,395 | 18.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 27 | $8,100 | $2,304 | 28.4% |
| 36471 | Injection of chemical agent into multiple incompetent veins of leg | Office | 2022 | 16 | 27 | $13,721 | $2,955 | 21.5% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2022 | 17 | 17 | $7,650 | $2,424 | 31.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 24 | 24 | $9,000 | $1,998 | 22.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 16 | $4,800 | $1,139 | 23.7% |
| 36475 | Destruction of insufficient vein of arm or leg, accessed through the skin | Office | 2021 | 13 | 17 | $77,058 | $17,480 | 22.7% |
| 36471 | Injection of chemical agent into multiple incompetent veins of one leg | Office | 2021 | 20 | 30 | $15,246 | $3,352 | 22.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 21 | 21 | $7,875 | $1,901 | 24.1% |
| 36475 | Destruction of insufficient vein of arm or leg, accessed through the skin | Office | 2020 | 16 | 25 | $113,320 | $30,274 | 26.7% |
| 36471 | Injection of chemical agent into multiple incompetent veins of one leg | Office | 2020 | 23 | 34 | $17,279 | $3,294 | 19.1% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 13 | 13 | $4,875 | $1,038 | 21.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 12 | 12 | $3,600 | $965.88 | 26.8% |
About Dr. Christopher Rubano, MD
Dr. Christopher Rubano, MD is a Surgery healthcare provider based in Vancouver, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861430506.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Rubano, MD has received a total of $2,042 in payments from pharmaceutical and medical device companies, with $379.91 received in 2023. These payments were reported across 93 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($2,042).
As a Medicare-enrolled provider, Rubano has provided services to 325 Medicare beneficiaries, totaling 393 services with total Medicare billing of $108,256. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Surgery
- Location Vancouver, WA
- Active Since 06/03/2006
- Last Updated 07/10/2018
- Taxonomy Code 208600000X
- Entity Type Individual
- NPI Number 1861430506
Products in Payments
- NOCDURNA (Drug) $589.73
- XYOSTED (Drug) $463.26
- VenaSeal (Device) $244.78
- ClosureFast (Device) $147.19
- REXULTI (Drug) $76.85
- OTREXUP (Drug) $65.27
- QELBREE (Drug) $60.07
- Azstarys (Drug) $59.13
- VENASEAL (Device) $56.52
- NURTEC ODT (Drug) $41.62
- Ozempic (Drug) $27.83
- ENSEAL Product Family (Device) $25.23
- Wegovy (Drug) $22.98
- EVRSF (Device) $21.83
- VAC VERAFLO (Device) $20.71
- Sunosi (Drug) $20.37
- TLANDO (Drug) $19.45
- TRINTELLIX (Drug) $17.00
- iDrive Ultra (Device) $14.74
- PREMARIN (Drug) $13.67
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgery Doctors in Vancouver
Allen Gabriel, Md, MD
Surgery — Payments: $1.4M
Toni Storm, Md, MD
Surgery — Payments: $254,017
Dr. Jeffrey Watkins, M.d, M.D
Surgery — Payments: $14,196
Dr. Mark Eichler, M.d, M.D
Surgery — Payments: $13,063
Leslie Disher, Do, DO
Surgery — Payments: $11,210
Reid Fletcher, M.d, M.D
Surgery — Payments: $7,821